Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,518
Closed -$244K 82
2016
Q3
$244K Buy
4,518
+80
+2% +$4.39K 0.13% 73
2016
Q2
$240K Hold
4,438
0.12% 78
2016
Q1
$225K Hold
4,438
0.13% 74
2015
Q4
$224K Hold
4,438
0.11% 78
2015
Q3
$213K Hold
4,438
0.11% 76
2015
Q2
$231K Hold
4,438
0.1% 85
2015
Q1
$256K Hold
4,438
0.11% 83
2014
Q4
$237K Hold
4,438
0.1% 84
2014
Q3
$255K Sell
4,438
-78,394
-95% -$4.81M 0.11% 80
2014
Q2
$5.54M Buy
82,832
+2,477
+3% +$168K 2.36% 16
2014
Q1
$5.37M Buy
80,355
+288
+0.4% +$19.5K 2.39% 16
2013
Q4
$5.34M Buy
80,067
+74,029
+1,226% +$4.8M 2.39% 17
2013
Q3
$379K Hold
6,038
0.18% 60
2013
Q2
$377K Buy
+6,038
New +$383K 0.2% 56

Other funds holding GSK

Bar Harbor Trust Services's GSK Position: Q4 2016 in Review

Bar Harbor Trust Services sold out of GSK (GSK) in Q4 2016, closing a stake of 4,518 shares — an estimated $244K sold.

Bar Harbor Trust Services first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $5.54M in Q2 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Bar Harbor Trust Services reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Bar Harbor Trust Services sold 4,518 GSK shares in Q4 2016, an estimated $244K.
  • Bar Harbor Trust Services first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Bar Harbor Trust Services's GSK position peaked at $5.54M in Q2 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Bar Harbor Trust Services's 13F filing for Q4 2016, filed 7 Feb 2017.